Close

Analyst Ratings for Intellia Therapeutics (NTLA)

NTLA Rating Summary

NTLA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NTLA
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $116.39 (+85.7%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/21/2022 JPMorgan Brian Cheng New Coverage Overweight
(N/A)
85.00
(N/A)
62.53
(62.69)
0.26% Details
9/1/2022 Citi David Lebowitz New Coverage Sell
(N/A)
50.00
(N/A)
60.24
(62.69)
4.07% Details
Like NTLA Ratings? Also take a look at REGN, CRSP, EDIT, FUSN

NTLA Ratings News